Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed Mahmood(NewYork–Presbyterian Hospital), Tomas G. Neilan(Albert Einstein College of Medicine), Malek Hassan(Massachusetts General Hospital), Javid J. Moslehi(Cardiovascular Institute of the South), John D. Groarke(Edinburgh Cancer Research), Sachin Shah(Lahey Medical Center), Kerry L. Reynolds(Massachusetts General Hospital), Lucie Heinzerling(LMU Klinikum), Justine V. Cohen(Massachusetts General Hospital), Magid Awadalla(Massachusetts General Hospital), Carol L. Chen(Memorial Sloan Kettering Cancer Center), Michael Constantin Kirchberger(Friedrich-Alexander-Universität Erlangen-Nürnberg), Donald P. Lawrence(Massachusetts General Hospital), Rongras Damrongwatanasuk(University of South Florida), Sarju Ganatra(Lahey Hospital and Medical Center), Michael G. Fradley(University of South Florida), Paaladinesh Thavendiranathan(University of Toronto), Anju Nohria(Brigham and Women's Hospital), Dipti Gupta(Memorial Sloan Kettering Cancer Center), Ryan J. Sullivan(Dana-Farber Cancer Institute)
Cited by 1,532
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k